Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latent decrease » latency decreased (Expand Search), content decreased (Expand Search), greatest decrease (Expand Search)
laser decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latent decrease » latency decreased (Expand Search), content decreased (Expand Search), greatest decrease (Expand Search)
laser decrease » larger decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
-
381
-
382
-
383
-
384
-
385
-
386
-
387
-
388
Table_1_A whole cell-based Matrix-assisted laser desorption/ionization mass spectrometry lipidomic assay for the discovery of compounds that target lipid a modifications.xlsx
Published 2023“…Introduction<p>Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) is a powerful analytical technique that has been applied to a wide variety of applications ranging from proteomics to clinical diagnostics. …”
-
389
-
390
ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alo...
Published 2021“…After treatment, best-corrected visual acuity was significantly (p<0.05) improved at all follow-up visits in the group receiving intravitreal injection alone, at all but week 4 in the ETDRS group, and at all but weeks 4 and 8 for the PASCAL group. A significant decrease in central subfield macular thickness was observed in the PASCAL group at weeks 4, 8, and 48; only at week 48 in the intravitreal injection group; and never in the ETDRS group. …”
-
391
-
392
-
393
-
394
-
395
-
396
-
397
-
398
-
399
Participant retention flowchart.
Published 2025“…We identified a 4-class solution: (1) severe with appetite decrease, (2) severe with appetite increase, (3) moderate severity and (4) low severity. …”
-
400